Article

Guidelines help to measure burden

There is no shortage of studies to measure the costs of visual impairment, but because the studies use a variety of approaches to analyze data, it has been difficult to draw conclusions.

There is no shortage of studies that measure the costs of visual impairment, to individuals and to specific countries.

In 2007, the Association for Research in Vision and Ophthalmology (ARVO) and the International Agency for the Prevention of Blindness convened a workshop in Vancouver, British Columbia to develop consensus on best practices for measuring the burden of vision loss.

"When estimates of the cost of visual impairment vary over time or across countries," explained lead author Kevin Frick, PhD, from Johns Hopkins University, "policy makers are left to ponder whether one estimate differs from another because of changes in the population, changes in the impact of the disease, or changes in the methods. Researchers can help policy makers by removing one of the potential variables: changes in methods."

Co-author Steven Kymes, PhD, from Washington University in St. Louis, added: "Higher-quality studies using a methodology that consistently follows guidelines will help decision makers and advocates in the ophthalmology community to [understand better] the magnitude of the impact of visual impairment, how it is likely to change with demographic changes and no additional interventions, and how additional interventions can change the impact over time."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.